Biao Xu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Nanomedicine (London, England)

Cardiovascular research

Cardiovascular drugs and therapy

European journal of preventive cardiology

Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital

China

chairman :: Cardiology

Publications

Lintao Wang, Wu Luo, Suya Zhang, Junsheng Zhang, Lu He, Yifan Shi, Li Gao, Baochuan Wu, Xiaoyan Nie, Chenghong Hu, Xue Han, Chaoyong He, Biao Xu, Guang Liang
Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signaling pathway. Cardiovascular research (2024)
Ying Tan, Xun Wang, Yu Gu, Xue Bao, He Lu, Xuan Sun, Lina Kang, Biao Xu
Neutrophil and endothelial cell membranes coassembled roflumilast nanoparticles attenuate myocardial ischemia/reperfusion injury. Nanomedicine (London, England) (2024)
Ying Tan, Xun Wang, Yu Gu, Xue Bao, He Lu, Xuan Sun, Lina Kang, Biao Xu
Neutrophil and endothelial cell membranes coassembled roflumilast nanoparticles attenuate myocardial ischemia/reperfusion injury. Nanomedicine (London, England) 19 (9) (2024)
Ying Tan, Xun Wang, Yu Gu, Xue Bao, He Lu, Xuan Sun, Lina Kang, Biao Xu
Neutrophil and endothelial cell membranes coassembled roflumilast nanoparticles attenuate myocardial ischemia/reperfusion injury. Nanomedicine (London, England) 19 (9) (2024)
Ying Tan, Xun Wang, Yu Gu, Xue Bao, He Lu, Xuan Sun, Lina Kang, Biao Xu
Neutrophil and endothelial cell membranes coassembled roflumilast nanoparticles attenuate myocardial ischemia/reperfusion injury. Nanomedicine (London, England) 19 (9) (2024)
Xue Bao, Biao Xu, Lars Lind, Gunnar Engström
Carotid ultrasound and Systematic Coronary Risk Assessment 2 (SCORE2) in the prediction of cardiovascular events. European journal of preventive cardiology (2023)
Ying Tan, Xue Bao, Yuyu Li, Guo Song, He Lu, Xuan Sun, Rong Gu, Lina Kang, Biao Xu
Colchicine Attenuates Microvascular Obstruction after Myocardial Ischemia-Reperfusion Injury by Inhibiting the Proliferation of Neutrophil in Bone Marrow. Cardiovascular drugs and therapy (2023)
Jinxuan Zhao, Qi Zhang, Wei Cheng, Qing Dai, Zhonghai Wei, Meng Guo, Fu Chen, Shuaihua Qiao, Jiaxin Hu, Junzhuo Wang, Haiting Chen, Xue Bao, Dan Mu, Xuan Sun, Biao Xu, Jun Xie
Heart-gut-microbiota communication determines the severity of cardiac injury after myocardial ischemia/reperfusion. Cardiovascular research (2023)
Xue Bao, Biao Xu, Iram Faqir Muhammad, Peter M Nilsson, Jan Nilsson, Gunnar Engström
Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality. Diabetologia 65 (10) (2022)
Xue Bao, Biao Xu, Songjiang Yin, Jingxue Pan, Peter M Nilssson, Jan Nillson, Olle Melander, Marju Orho-Melander, Gunnar Engström
Proteomic Profiles of Body Mass Index and Waist-to-Hip Ratio and Their Role in Incidence of Diabetes. The Journal of clinical endocrinology and metabolism 107 (7) (2022)
Han Wu, Ran Li, Kun Wang, Dan Mu, Jian-Zhou Chen, Xuan Wei, Xue Bao, Zhong-Hai Wei, Jun Xie, Biao Xu
Predictive Value of Fasting Blood Glucose for Microvascular Obstruction in Nondiabetic Patients with ST-Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention. Cardiology research and practice 2020 (2020)

Biao Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Biao Xu